Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.2bn reported value +46.6% vs Q4 2020
74positions
50.0%in top 10
33 new 24 added 16 reduced 17 sold out vs Q4 2020

Options: 8 call positions ($63.1m notional), 3 put positions ($46.5m notional) – listed below, not included above.

Holdings, Q1 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 16,896,796 $104.9m8.60% 8.60% AddedShares held: Q2 2020 4.8m, Q3 2020 10.7m, Q4 2020 15.9m, Q1 2021 16.9m +952.9k +952,881 6.0%
2 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 486,529 $81.4m6.67% 6.67% AddedShares held: Q2 2020 232.7k, Q3 2020 240.9k, Q4 2020 458.6k, Q1 2021 486.5k +27.9k +27,893 6.1%
3 ARK ETF TR GENOMIC REV ETF ARKG ARKG 806,932 $71.6m5.87% 5.87% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 806.9k
4 ALEXION PHARMACEUTICALS INC COM ALXN ALXN 465,983 $71.3m5.84% 5.84% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 376.2k, Q1 2021 466.0k +89.8k +89,783 23.9%
5 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 695,459 $64.0m5.24% 5.24% AddedShares held: Q2 2020 954.7k, Q3 2020 607.8k, Q4 2020 531.0k, Q1 2021 695.5k +164.5k +164,483 31.0%
6 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 4,354,756 $50.3m4.12% 4.12% AddedShares held: Q2 2020 0, Q3 2020 2.4m, Q4 2020 2.7m, Q1 2021 4.4m +1.6m +1,606,506 58.5%
7 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 992,315 $49.3m4.04% 4.04% AddedShares held: Q2 2020 562.2k, Q3 2020 60.9k, Q4 2020 852.4k, Q1 2021 992.3k +139.9k +139,884 16.4%
8 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 311,867 $40.2m3.29% 3.29% AddedShares held: Q2 2020 220.3k, Q3 2020 161.0k, Q4 2020 187.0k, Q1 2021 311.9k +124.8k +124,824 66.7%
9 DANAHER CORPORATION COM DHR DHR 177,534 $40.0m3.28% 3.28% AddedShares held: Q2 2020 107.9k, Q3 2020 31.4k, Q4 2020 126.3k, Q1 2021 177.5k +51.2k +51,204 40.5%
10 TG THERAPEUTICS INC COM TGTX TGTX 762,589 $36.8m3.01% 3.01% ReducedShares held: Q2 2020 2.5m, Q3 2020 1.0m, Q4 2020 863.9k, Q1 2021 762.6k -101.3k -101,262 -11.7%
11 ACCELERON PHARMA INC COM XLRN XLRN 241,981 $32.8m2.69% 2.69% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 242.0k
12 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 2,405,834 $32.5m2.66% 2.66% AddedShares held: Q2 2020 492.3k, Q3 2020 0, Q4 2020 12.8k, Q1 2021 2.4m +2.4m +2,393,029 18688.2%
13 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 4,755,480 $32.0m2.62% 2.62% AddedShares held: Q2 2020 886.6k, Q3 2020 2.7m, Q4 2020 1.2m, Q1 2021 4.8m +3.6m +3,577,327 303.6%
14 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 852,206 $31.1m2.54% 2.54% ReducedShares held: Q2 2020 227.3k, Q3 2020 64.4k, Q4 2020 946.6k, Q1 2021 852.2k -94.4k -94,375 -10.0%
15 ENVISTA HOLDINGS CORPORATION COM NVST NVST 732,684 $29.9m2.45% 2.45% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 861.4k, Q1 2021 732.7k -128.7k -128,671 -14.9%
16 AVANTOR INC COM AVTR AVTR 958,987 $27.7m2.27% 2.27% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 920.6k, Q1 2021 959.0k +38.3k +38,337 4.2%
17 ORTHO CLINICAL DIAGNOSTICS H ORD SHS OCDX OCDX 1,375,228 $26.5m2.17% 2.17% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.4m
18 FATE THERAPEUTICS INC COM FATE FATE 321,760 $26.5m2.17% 2.17% ReducedShares held: Q2 2020 531.3k, Q3 2020 535.0k, Q4 2020 399.5k, Q1 2021 321.8k -77.7k -77,739 -19.5%
19 MCKESSON CORP COM MCK MCK 122,983 $24.0m1.97% 1.97% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 123.0k
20 ELEVANCE HEALTH INC COM ELV ELV 63,892 $22.9m1.88% 1.88% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 65.8k, Q1 2021 63.9k -1.9k -1,879 -2.9%
21 QIAGEN NV SHS NEW SHS NEW 454,721 $22.1m1.81% 1.81% AddedShares held: Q2 2020 82.5k, Q3 2020 167.5k, Q4 2020 336.9k, Q1 2021 454.7k +117.9k +117,859 35.0%
22 CATALENT INC COM CTLT CTLT 163,114 $17.2m1.41% 1.41% ReducedShares held: Q2 2020 0, Q3 2020 140.3k, Q4 2020 279.5k, Q1 2021 163.1k -116.4k -116,389 -41.6%
23 BECTON DICKINSON & CO COM BDX BDX 68,383 $16.6m1.36% 1.36% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 68.4k
24 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 242,172 $16.6m1.36% 1.36% AddedShares held: Q2 2020 448.3k, Q3 2020 321.6k, Q4 2020 103.8k, Q1 2021 242.2k +138.4k +138,408 133.4%
25 HCA HEALTHCARE INC COM HCA HCA 85,409 $16.1m1.32% 1.32% AddedShares held: Q2 2020 30.4k, Q3 2020 52.4k, Q4 2020 16.8k, Q1 2021 85.4k +68.7k +68,655 409.8%
26 ZOGENIX INC COM NEW ZGNX ZGNX 823,229 $16.1m1.32% 1.32% ReducedShares held: Q2 2020 1.0m, Q3 2020 865.2k, Q4 2020 909.7k, Q1 2021 823.2k -86.5k -86,479 -9.5%
27 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 345,717 $15.5m1.27% 1.27% AddedShares held: Q2 2020 418.7k, Q3 2020 402.4k, Q4 2020 246.2k, Q1 2021 345.7k +99.5k +99,477 40.4%
28 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 164,378 $12.1m0.99% 0.99% AddedShares held: Q2 2020 105.2k, Q3 2020 141.9k, Q4 2020 152.3k, Q1 2021 164.4k +12.1k +12,122 8.0%
29 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 80,937 $11.4m0.94% 0.94% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 80.9k
30 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 420,000 $10.8m0.89% 0.89% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 420.0k
31 HUMANA INC COM HUM HUM 24,839 $10.4m0.86% 0.86% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 24.8k
32 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 300,587 $10.2m0.84% 0.84% ReducedShares held: Q2 2020 0, Q3 2020 176.8k, Q4 2020 356.2k, Q1 2021 300.6k -55.6k -55,648 -15.6%
33 ARGENX SE SPONSORED ADR ARGX ARGX 35,886 $9.9m0.81% 0.81% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 35.9k
34 ARK ETF TR INNOVATION ETF ARKK ARKK 82,000 $9.8m0.81% 0.81% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 82.0k
35 MAGELLAN HEALTH INC COM NEW MGLN MGLN 104,700 $9.8m0.80% 0.80% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 104.7k, Q1 2021 104.7k
36 THE CIGNA GROUP COM CI CI 40,000 $9.7m0.79% 0.79% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 40.0k
37 MANNKIND CORP COM NEW MNKD MNKD 2,165,383 $8.5m0.70% 0.70% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 2.2m
38 AFFIMED N V COM COM 1,046,129 $8.3m0.68% 0.68% AddedShares held: Q2 2020 943.0k, Q3 2020 1.2m, Q4 2020 964.7k, Q1 2021 1.0m +81.4k +81,422 8.4%
39 DEXCOM INC COM DXCM DXCM 18,741 $6.7m0.55% 0.55% AddedShares held: Q2 2020 6.7k, Q3 2020 0, Q4 2020 2.5k, Q1 2021 18.7k +16.3k +16,268 657.8%
40 GUARDANT HEALTH INC COM GH GH 40,247 $6.1m0.50% 0.50% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 40.2k
41 NOVAVAX INC COM NEW NVAX NVAX 33,473 $6.1m0.50% 0.50% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 33.5k
42 NATERA INC COM NTRA NTRA 57,700 $5.9m0.48% 0.48% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 57.7k
43 CENTENE CORP DEL COM CNC CNC 91,120 $5.8m0.48% 0.48% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 91.1k
44 SURGALIGN HOLDINGS INC COM RTIX RTIX 2,639,784 $5.8m0.47% 0.47% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 2.6m
45 KADMON HLDGS INC COM KDMN KDMN 1,373,119 $5.3m0.44% 0.44% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 2.4m, Q1 2021 1.4m -1.0m -1,035,766 -43.0%
46 SERES THERAPEUTICS INC COM COM 215,276 $4.4m0.36% 0.36% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 334.0k, Q1 2021 215.3k -118.8k -118,773 -35.6%
47 LUMINEX CORP DEL COM COM 135,471 $4.3m0.35% 0.35% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 135.5k
48 IMMUNOVANT INC COM IMVT IMVT 230,183 $3.7m0.30% 0.30% NewShares held: Q2 2020 12.3k, Q3 2020 0, Q4 2020 0, Q1 2021 230.2k
49 FIVE PRIME THERAPEUTICS INC COM FPRX FPRX 93,280 $3.5m0.29% 0.29% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 209.2k, Q1 2021 93.3k -115.9k -115,875 -55.4%
50 ENSIGN GROUP INC COM ENSG ENSG 28,883 $2.7m0.22% 0.22% ReducedShares held: Q2 2020 427.3k, Q3 2020 318.9k, Q4 2020 208.5k, Q1 2021 28.9k -179.6k -179,587 -86.2%
51 SURMODICS INC COM SRDX SRDX 47,906 $2.7m0.22% 0.22% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 41.3k, Q1 2021 47.9k +6.6k +6,607 16.0%
52 ALPHA HEALTHCARE ACQUISTN CO CL A CL A 239,026 $2.6m0.21% 0.21% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 239.0k
53 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 410,593 $2.4m0.20% 0.20% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 410.6k
54 AGILENT TECHNOLOGIES INC COM A A 15,261 $1.9m0.16% 0.16% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 5.0k, Q1 2021 15.3k +10.3k +10,284 206.6%
55 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 2,583 $1.9m0.16% 0.16% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 2.6k
56 HESKA CORP COM RESTRC NEW HSKA HSKA 11,040 $1.9m0.15% 0.15% ReducedShares held: Q2 2020 280.3k, Q3 2020 158.8k, Q4 2020 76.2k, Q1 2021 11.0k -65.1k -65,126 -85.5%
57 EXAGEN INC COM XGN XGN 104,437 $1.8m0.15% 0.15% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 81.6k, Q1 2021 104.4k +22.8k +22,834 28.0%
58 PROTHENA CORP PLC SHS PRTA PRTA 68,575 $1.7m0.14% 0.14% ReducedShares held: Q2 2020 152.2k, Q3 2020 197.0k, Q4 2020 203.3k, Q1 2021 68.6k -134.8k -134,753 -66.3%
59 KEROS THERAPEUTICS INC COM KROS KROS 27,631 $1.7m0.14% 0.14% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 27.6k
60 INTERSECT ENT INC COM XENT XENT 75,389 $1.6m0.13% 0.13% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 75.4k
61 TELIGENT INC NEW COM NEW COM NEW 2,500,260 $1.6m0.13% 0.13% NewShares held: Q2 2020 355.0k, Q3 2020 305.4k, Q4 2020 0, Q1 2021 2.5m
62 CONFORMIS INC COM NEW CFMS CFMS 1,541,978 $1.5m0.13% 0.13% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.5m
63 LIQUIDIA CORPORATION COM NEW LQDA LQDA 500,010 $1.3m0.11% 0.11% NewShares held: Q2 2020 859.7k, Q3 2020 182.8k, Q4 2020 0, Q1 2021 500.0k
64 IQVIA HLDGS INC COM IQV IQV 5,921 $1.1m0.09% 0.09% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 4.1k, Q1 2021 5.9k +1.8k +1,836 44.9%
65 CHEWY INC CL A CHWY CHWY 13,100 $1.1m0.09% 0.09% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 13.1k
66 RITE AID CORP COM RAD RAD 54,025 $1.1m0.09% 0.09% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 532.0k, Q1 2021 54.0k -478.0k -477,979 -89.8%
67 INFLARX NV COM IFRX IFRX 268,634 $1.0m0.09% 0.09% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 268.6k
68 CABALETTA BIO INC COM CABA CABA 76,849 $853.0k0.07% 0.07% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 76.8k
69 GOHEALTH INC COM CL A COM CL A 68,899 $805.4k0.07% 0.07% AddedShares held: Q2 2020 0, Q3 2020 13.1k, Q4 2020 29.7k, Q1 2021 68.9k +39.2k +39,214 132.1%
70 IMMUTEP LTD SPONSORED ADS SPONSORED ADS 249,895 $767.2k0.06% 0.06% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 249.9k
71 APELLIS PHARMACEUTICALS INC COM APLS APLS 12,900 $553.5k0.05% 0.05% AddedShares held: Q2 2020 420.9k, Q3 2020 81.3k, Q4 2020 3.8k, Q1 2021 12.9k +9.1k +9,084 238.1%
72 QUIDEL CORP COM QDEL QDEL 4,132 $528.6k0.04% 0.04% ReducedShares held: Q2 2020 0, Q3 2020 9.3k, Q4 2020 40.6k, Q1 2021 4.1k -36.5k -36,451 -89.8%
73 APTOSE BIOSCIENCES INC COM NEW COM NEW 80,000 $478.0k0.04% 0.04% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 80.0k
74 REPLIGEN CORP COM RGEN RGEN 1,428 $277.6k0.02% 0.02% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.4k

Sold out since Q4 2020

SecurityTickerShares held beforeValue then
SAREPTA THERAPEUTICS INC SRPT SRPT 138,644 $23.6m138.6k shares
AURINIA PHARMACEUTICALS INC AUPH AUPH 604,368 $8.4m604.4k shares
OXFORD IMMUNOTEC GLOBAL PLC OXFD OXFD 307,742 $5.4m307.7k shares
ALTIMMUNE INC ALT ALT 380,000 $4.3m380.0k shares
BIOCRYST PHARMACEUTICALS INC BCRX BCRX 491,852 $3.7m491.9k shares
SANOFI SNY SNY 68,138 $3.3m68.1k shares
SESEN BIO INC 1,559,824 $2.1m1.6m shares
ANAPTYSBIO INC ANAB ANAB 88,334 $1.9m88.3k shares
ONCTERNAL THERAPEUTICS INC GTXI GTXI 344,090 $1.7m344.1k shares
OTONOMY INC OTIC OTIC 253,283 $1.6m253.3k shares
AUTOLUS THERAPEUTICS PLC AUTL AUTL 154,981 $1.4m155.0k shares
CONCERT PHARMACEUTICALS INC CNCE CNCE 103,829 $1.3m103.8k shares
CATABASIS PHARMACEUTICALS IN CATB CATB 522,042 $1.1m522.0k shares
PROTARA THERAPEUTICS INC TARA TARA 36,310 $879.1k36.3k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 18,925 $359.4k18.9k shares
ZYMEWORKS INC ZYME ZYME 5,405 $255.4k5.4k shares
MERUS N V MRUS MRUS 14,445 $253.2k14.4k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
GLAXOSMITHKLINE PLC Call Call 1,154,100 $41.2m1.2m shares Added
SPDR S&P 500 ETF TR SPY · Put SPYPut 100,000 $39.6m100.0k shares New
VERTEX PHARMACEUTICALS INC VRTX · Call VRTXCall 60,000 $12.9m60.0k shares New
ARK ETF TR ARKG · Put ARKGPut 56,900 $5.0m56.9k shares New
CENTENE CORP DEL CNC · Call CNCCall 50,000 $3.2m50.0k shares New
AMARIN CORP PLC Call Call 440,800 $2.7m440.8k shares Reduced
FREQUENCY THERAPEUTICS INC Put Put 193,600 $1.8m193.6k shares New
NOVAVAX INC NVAX · Call NVAXCall 10,000 $1.8m10.0k shares New
ACADIA PHARMACEUTICALS INC ACAD · Call ACADCall 25,000 $645.0k25.0k shares New
OTONOMY INC OTIC · Call OTICCall 198,400 $505.9k198.4k shares New
FREQUENCY THERAPEUTICS INC Call Call 10,000 $94.8k10.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17